Table 2.
Patient and treatment characteristics
| Number | % | Mean | Minimum | Maximum | |
|---|---|---|---|---|---|
| Age (years) | 43 | 64 | 32 | 87 | |
| Sex | |||||
| Male | 25 | 58.1 | – | – | – |
| Female | 18 | 41.9 | – | – | – |
| Pretreatment performance scale (Karnofsky index; %) | – | – | 80 | 60 | 90 |
| Disease sites treated | 48 | – | – | – | – |
| Abdominal lymph node metastases | 11 | 22.9 | – | – | – |
| Liver lesions | 8 | 16.6 | – | – | – |
| Pelvic lymph node metastases | 5 | 10.4 | – | – | – |
| Bone metastases | 5 | 10.4 | – | – | – |
| Adrenal metastases | 4 | 8.2 | – | – | – |
| Mediastinal lymph node metastases | 3 | 6.3 | – | – | – |
| Cardiac tumors | 3 | 6.3 | – | – | – |
| Pulmonary lesions | 3 | 6.3 | – | – | – |
| Prostate cancer | 2 | 4.2 | – | – | – |
| Partial breast | 1 | 2.1 | – | – | – |
| Others | 3 | 6.3 | – | – | – |
| Single fraction dose (Gy) | 48 | – | 5 | 2 | 15 |
| Total dose (Gy) | 48 | – | 37 | 4 | 66 |
| Number of fractions | 48 | – | 9 | 2 | 33 |